In eukaryotes, the elimination of the m 7
GpppN mRNA cap, a process known as decapping, is a critical, largely irreversible and highly regulated step of mRNA decay that withdraws the targeted mRNAs from the pool of translatable templates. The decapping reaction is catalysed by a multiprotein complex formed by the Dcp2 catalytic subunit and its Dcp1 cofactor, a holoenzyme that is poorly active on its own and needs several accessory proteins (Lsm1-7 complex, Pat1, Edc1 -2, Edc3 and/or EDC4) to be fully efficient. Here, we discuss the several crystal structures of Dcp2 domains bound to various partners ( proteins or small molecules) determined in the last couple of years that have considerably improved our current understanding of how Dcp2, assisted by its various activators, is recruited to its mRNA targets and adopts its active conformation upon substrate recognition. We also describe how, over the years, elegant integrative structural biology approaches combined to biochemistry and genetics led to the identification of the correct structure of the active Dcp1 -Dcp2 holoenzyme among the many available conformations trapped by X-ray crystallography.
This article is part of the theme issue '5 0 and 3 0 modifications controlling RNA degradation'.
Introduction
The control of mRNA decay is a key mechanism of gene expression regulation allowing cells to fine tune their repertoire of transcripts in response to various cellular events or external stimuli. In eukaryotes, mature mRNAs are protected from rapid and uncontrolled exonucleolytic degradation by a 5 0 m 7 GpppN cap (where N is any nucleotide) and a 3 0 poly(A) tail [1, 2] . A prerequisite to feed the cytoplasmic exonucleases responsible for mRNA degradation (Xrn1 and RNA exosome) is to generate 5 0 monophosphate or 3 0 deadenylated ends through either elimination of these stabilizing elements or endonucleolytic cleavage. Endonucleases are mainly involved in specific mRNA surveillance pathways [3, 4] and seem to have a relatively minor role in general yeast mRNA decay [5, 6] .
General mRNA decay is typically initiated by the shortening of the poly(A) tail, also known as deadenylation, through the combined action of the CCR4/ NOT and PAN2/3 complexes [7, 8] . Although mRNA degradation can then proceed in the 3 0 -5 0 direction via the recruitment of the cytoplasmic RNA exosome [9] , the main response to deadenylation occurs at the 5 0 -end with the elimination of the m 7 GDP cap moiety through a process known as 'mRNA decapping' [10] . This generates a transcript with a 5 0 monophosphate end that can be accommodated in the active site of the main cytoplasmic 5 0 -3 0 exonuclease Xrn1 for rapid degradation of the entire message [11] . Hence, mRNA decapping is commonly considered the ultimate step before rapid clearance of the message and is therefore subjected to extensive cellular regulations. Importantly, decapping defects can have deleterious consequences on cell development and have been recently linked to severe human neurological disorders [12, 13] .
Since decapping was shown to be an important mechanism of mRNA decay, the main actors of the decapping machinery have been identified and characterized, revealing the complexity of this crucial pathway in the mRNA life cycle. Nonetheless, the mechanisms responsible for the control of the decapping holoenzyme by its different cofactors and for substrate recognition had remained largely unknown until very recently. In this review, we summarize the latest advances made in the field of mRNA decapping and more specifically, we emphasize several crystal structures of multi-protein complexes that have considerably improved our knowledge on (i) the mechanisms involved in the recruitment of the decapping enzyme to targeted mRNAs, (ii) the molecular bases for cap recognition and hydrolysis, and (iii) the activation of decapping by various proteins known as enhancers of decapping.
Dcp2 and its team mates
The hydrolysis of the mRNA 5 0 cap is catalysed by the Dcp2 decapping enzyme, which contains a Nudix domain [14] [15] [16] . As in the other members of the Nudix hydrolase superfamily, this catalytic domain displays a consensus motif GX 5 EX 7-REUXEEXGU (where U is a hydrophobic residue and X is any amino acid), in which glutamic acid side chains coordinate divalent cations for catalysis [17] . In Dcp2 proteins, the Nudix domain is flanked by an N-terminal regulatory domain (NRD), essential for the decapping activity in vivo [18] , and a short C-terminal helical region partially integrated into the Nudix fold, known as Box B and important for RNA binding ( figure 1 ; [18] [19] [20] ). In yeasts, Box B is further extended by a disordered C-terminal domain (CTD) of variable length and composition. This CTD is neither essential for Saccharomyces cerevisiae development [14] nor required for decapping activity in vitro [21] . Nevertheless, it was recently shown to contain auto-inhibitory sequences [22, 23] as well as several protein-protein interaction motifs [22,24 -26] . The Dcp2 Nudix domain is endowed with a low catalytic activity in vitro [18, 19] that is enhanced by the NRD. The latter also ensures the specificity of the cleavage reaction between beta and alpha phosphate groups to produce m 7 GDP and 5 0 monophosphate RNAs [18, 19] . Dcp2 overall low catalytic activity is further stimulated by numerous accessory factors organized within a complex and dynamic network, which impacts the decapping activity at various levels ranging from substrate recognition and mRNP remodelling to direct enhancement of Dcp2 catalytic activity. These factors bind to the different domains surrounding the Nudix catalytic domain and include Dcp1, the Pat1 -Lsm1-7 complex, Edc1 -2 (Edc stands for enhancer of decapping), Edc3 as well as the metazoan-specific EDC4 [22,24,27 -33] (table 1 for a list of decapping factors and their different names in yeast, fruit-fly and human). Additional factors such as Dhh1 and Scd6 have also been shown to influence decapping but probably in a more indirect manner (table 1) .
Dcp1, the main cofactor of Dcp2, is essential for the decapping activity in vivo [27] and strongly enhances Dcp2 enzymatic activity in vitro [18, 20, 34] . Hence, the Dcp1 -Dcp2 complex has often been referred to as the 'decapping holoenzyme'. Dcp1 consists of an EVH1 domain that interacts with the Dcp2 NRD (figure 1; [35, 36] ). This domain also uses an aromatic cleft to recognize proline rich sequences (PRS) present in various components of the decay machinery, including yeast Edc1 and Edc2 proteins as well as their metazoan orthologue PNRC2 and probably PNRC1 [37] [38] [39] [40] .
In S. cerevisiae, Edc1 and Edc2 are decapping factors localized in the cytoplasm and the nucleolus [41] , respectively. They were initially identified as multi-copy suppressors of Dcp1 and Dcp2 mutant alleles in yeast [30] Edc3 is structurally unrelated to Edc1 -2 proteins because it is formed by an N-terminal LSm domain and a C-terminal YjeF-N domain connected by a long unstructured linker containing an FDF motif (figure 1; also found in Scd6 and Pat1). In S. cerevisiae, the Edc3 the LSm domain is responsible for the catalytic activation of the Dcp1 -Dcp2 holoenzyme through binding to a unique short linear motif named E3BM (for Edc3-binding motif ) located downstream of Box B in the Dcp2 CTD [22, 24, 26, 32] . In Schizosaccharomyces pombe, Edc3 also contacts the Dcp2 CTD but in this case through several short linear motifs named HLM (for helical leucine-rich motifs; [25] ). Interestingly, in metazoans, the EDC3 LSm domain also interacts with DCP1a-DCP2 holoenzyme but through binding to HLM fragments located in the C-terminal part of DCP1a [25, 44] . The Edc3 FDF motif interacts with Dhh1, a DEAD box ATPase with a possible helicase activity, which is notably involved in translation repression and co-translational decapping [45] [46] [47] [48] [49] . This FDF signature directly competes with similar motifs in Scd6 and Pat1 for Dhh1 binding both in yeast and human [50, 51] and affects Dhh1 mRNA binding capacity [51] . The YjeF-N domain of Edc3 binds RNA and possesses dimerization properties important for the formation of cytoplasmic foci, also known as P-bodies, which are enriched in translationally repressed mRNAs and mRNA decay factors [52, 53] .
Pat1 is a strong decapping activator both in vivo and in vitro [28, 29, 32, 54] . It is composed of three main functional domains termed NTD (for N-terminal domain), Middomain and Pat1C (for Pat1 C-terminal domain; figure 1 ). Pat1 is generally considered a scaffolding protein for the decapping machinery owing to the multiple physical interactions between its domains and the various RNA decay factors [32] . Each domain interacts with distinct decapping factors and is implicated in different mechanisms of decapping enhancement. The unstructured Pat1 NTD represses translation [32] and encompasses the FDF motif which contacts Dhh1 in a mutually exclusive manner with Edc3 and RNA [51] . The NTD and/or Mid-domain of Pat1 were reported to bind Scd6, a protein also involved in the inhibition of translation by targeting the initiation factor eIF4G [32, 55] . Finally, Pat1C is the most conserved and only folded domain of Pat1 and is characterized by a succession of a-helical repeats forming a solenoid structure [56, 57] . In yeast, this domain is responsible for the direct enhancement of the decapping activity in vitro [32] . Crystal structures of human and S. cerevisiae Pat1C domains revealed the presence of (i) a conserved and basic region at its N-terminal extremity that is involved in the interaction with the Lsm1-7 complex [56 -58] , and (ii) a fungi-specific C-terminal region ( present in Pat1 proteins from many Ascomycota, including Saccharomyces, Schizosacharomyces among others, and also from some Basidiomycota) that recruits Dcp2 and Xrn1 mRNA decay factors [33, 57] .
In metazoans, EDC4, an additional decapping factor, stabilizes the interaction between DCP1a and DCP2 but the exact molecular bases for the interaction of this protein with the decapping complex are still lacking [31, 59, 60] .
This decapping interaction network is characterized by numerous redundant and multivalent interactions, which often involve low complexity regions flanking the folded domains of the decapping factors [61] . These low complexity regions are prone to rapid evolution in the absence of selective pressure to maintain a specific three-dimensional structure. As a consequence, while most of the decapping factors, as well as the general mechanisms underlying decapping control, are thought to be conserved in eukaryotes, the decapping interaction networks differ substantially between species owing to fast rewiring during evolution but converge towards the same goal, i.e. coordinated mRNA decay from the 5 0 -end.
Recruiting the decapping and 5
0 -to-3 0 mRNA decay machineries to their substrates Canonical cytoplasmic mRNA decay typically initiates by the deadenylation step through the combined actions of the CCR4/NOT and PAN2/3 complexes, which trim the poly(A) tail down to a length of 5 -10 adenines in yeast [7] . The resulting oligo-adenylated mRNAs are mainly addressed to 5 0 -3 0 decay via decapping followed by Xrn1-mediated exonucleolytic degradation. These steps involve three distinct catalytic machineries that must be optimally coordinated to ensure rapid decay of the message and to prevent the accumulation of potentially toxic degradation intermediates. In particular, the decapping machinery has to be specifically recruited to mRNAs that have undergone the deadenylation step. This is largely mediated by the Pat1 -Lsm1-7 complex, which binds to the 3 0 -end of oligo-adenylated mRNAs and promotes the decapping reaction at their 5 0 -end [28, 29, 32, 62] .
(a) The Pat1-Lsm1-7 complex connects 3 0 -and 5 0 -ends from deadenylated mRNAs for decay
In eukaryotes, eight Sm-like proteins (Lsm1 -Lsm8) assemble in two doughnut-shaped heptameric rings of distinct cellular sub-localization and functions. While the nuclear Lsm2-8 complex is involved in spliceosome biogenesis through its interaction with the U6 snRNA [63, 64] , the cytoplasmic Lsm1-7 complex is a key player of the 5 0 -3 0 decay pathway Table 1 . List of proteins known to be involved in decapping and their names in the main organisms used to study decapping mechanism.
yeasts (S. cerevisiae and S. pombe)
rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 373: 20180164 [28, 29] . Specifically, deletion of the Lsm1 subunit of the Lsm1-7 complex results in the accumulation of deadenylated mRNAs still harbouring an intact cap, suggesting that this complex is required for normal decapping rates in vivo [28] . The Lsm1-7 ring preferentially recognizes U-rich sequences proximal to the 3 0 -end of cytoplasmic mRNAs produced by the deadenylation step, i.e. oligo-adenylated over polyadenylated mRNAs (figure 2, step A; [62, 65] ). Thereby, it protects approximately 30 nucleotides at the 3 0 -end of oligoadenylated mRNAs from the action of the 3 0 -5 0 exonucleases. The Lsm1-7 also tightly associates with Pat1 [28, 29] , which interacts with several 5 0 -3 0 decay machinery components [32] . Thus, the Pat1-Lsm1-7 complex is ideally poised to dictate the directionality of the degradation from the mRNA 5 0 -end after deadenylation [66, 67] . Detailed information on the interaction between these proteins was obtained from crystal structures of the yeast Pat1 C-terminal domain (Pat1C) bound to either the Lsm1-7 complex [58] or the Lsm2-3 sub-complex [68] . In both structures, the positively charged and conserved surface at the N-terminal end of the Pat1C domain interacts with a composite surface formed by the Lsm2 and Lsm3 subunits. This mode of interaction is very likely to be conserved in metazoans such as fruit-fly and human, according to site-directed mutagenesis data (figure 2, step A [56, 57] ). The Pat1 Middomain also contributes to the interaction with the Lsm1-7 complex and is important for the functionality of the Pat1 -Lsm1-7 complex, but the molecular details of such an interaction are still missing [56, 69] . As Pat1 binds poly(U) RNAs [56, 70] , it could also directly participate in mRNA binding by the Pat1 -Lsm1-7 complex. Despite extensive biochemical, genetic and structural characterization, the reasons for the selective binding of the Pat1 -Lsm1-7 complex to oligoadenylated mRNAs targeted for decay remain largely unknown. A structure of Pat1, encompassing Mid-and Pat1C domains, bound to the Lsm1-7 complex and an RNA fragment would be highly valuable to uncover the molecular bases for such an enigmatic function.
Importantly, the coordination between deadenylation and decapping does certainly not only rely on the sole ability of the Pat1-Lsm1-7 complex to target oligo-adenylated mRNAs. Indeed, the crosstalk between deadenylation and downstream decay steps is further strengthened by physical interactions between Pat1 and the deadenylation machinery itself, which have been initially observed in metazoans and more recently in yeast [45,51,71 -74] . Altogether, this suggests that multiple redundant interactions may tether the decapping machinery to deadenylated mRNAs.
(b) Recruitment of the 5 0 -to-3 0 mRNA decay machineries by the Pat1-Lsm1 -7 complex
Since the identification of the Lsm1-7 complex, its direct connections with Pat1, the decapping enzyme and the 5 0 -to-3 0 exonuclease Xrn1 in S. cerevisiae yeast have been evident [28, 29] . Much of our knowledge on how Pat1 recruits the RNA decay enzymes is based on studies performed in S. cerevisiae, but several lines of evidence indicate that this mechanism differs from those existing in metazoan.
The structure of the S. cerevisiae Pat1C domain revealed the presence of a fungi-specific and conserved C-terminal region opposite to the Lsm1-7 binding site [57] . This specific region is responsible for the direct interaction of Pat1 with eight short linear motifs or HLMs present in the yeast Dcp2 CTD (figure 1; [22, 33] ). These HLMs are characterized by an LLXwL consensus sequence (where L is leucine, X any amino acid and w any hydrophobic amino acid [75] ). When rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 373: 20180164 interacting with Pat1, these HLMs fold as short amphiphilic a-helices, the hydrophobic part of which faces Pat1 [33] .
The presence of several Pat1 binding sites on a single Dcp2 protein could allow the concomitant recruitment of multiple mRNPs to be decapped and thereby enhance the decapping efficiency by increasing the local concentration in mRNA substrates ( figure 2, step B) . In addition, the simultaneous binding of multiple Pat1 -Lsm1-7 complexes to a single Dcp2 may hamper the self-inhibitory effect exerted by sequences located in its CTD [22] (see §5, Mode of action of the enhancers of decapping). Such a mechanism would ensure that S. cerevisiae Dcp2 gets activated only when bound to the Pat1-Lsm1-7 complex (as well as to other activators such as Edc1-2 and/or Edc3), i.e. when recruited to its mRNA substrate.
The deletion of the fungi-specific region from Pat1C or the mutation of two conserved residues present at the centre of the Dcp2 binding site on S. cerevisiae Pat1 resulted in thermosensitive growth phenotype [33, 57] . Interestingly, an S. cerevisiae strain expressing a Dcp2 protein lacking its CTD, i.e. devoid of the HLM peptides involved in Pat1 binding, grows perfectly well at 378C, indicating that this Pat1C region might have additional partners. This led to the identification of a unique HLM peptide in the divergent and disordered C-terminal region from Xrn1, a known physical partner of the yeast Pat1-Lsm1-7 complex [28, 32] . This Xrn1 region competes with Dcp2 HLMs to bind to the same surface on Pat1C (figure 2, step C [33] ). This mutually exclusive recruitment of Dcp2 and Xrn1 by Pat1-Lsm1-7 complex bound to oligo-adenylated mRNAs suggests an optimized and coordinated mechanism for the 5 0 -to-3 0 mRNA decay pathway in yeast. Indeed, the Pat1 -Lsm1-7 complex would sequentially recruit Dcp2 enzyme for cap hydrolysis and then, probably upon an mRNP remodelling event triggered by the removal of the cap, the Xrn1 exonuclease to the resulting 5 0 monophosphate end of the mRNA to be degraded (figure 2). This model is supported by the increased stability of a reporter mRNA in a yeast strain expressing a Pat1 mutant unable to interact with both Dcp2 and Xrn1 [33] .
The extension of this model to all fungal species is currently unclear as so far, HLMs present in S. pombe Dcp2 CTD were shown to mediate the interaction with only Edc3 and Scd6 [25] . Furthermore, a recent nuclear magnetic resonance (NMR) binding study reported direct competition between proline-rich sequences (PRS) from Pat1, Xrn1, Dhh1, Edc1 and Dcp2 to interact in vitro with S. pombe Dcp1 [43] . Further studies are needed to evaluate if the binding of PRS sequences from Pat1 and Dhh1 to Dcp1 have functional implications in S. pombe. If this turns out to be the case, it would strongly increase the complexity of the interaction network.
In metazoans, the mechanism for the recruitment of the decapping machinery by the Lsm1-7 complex must differ from that in yeast owing to the absence of the fungi-specific Pat1 C-terminal region [33, 56] . Furthermore, the decapping complex and Xrn1 seem to co-exist within the same complex in metazoans. Indeed, fruit-fly Xrn1 interacts via a prolinerich region with the EVH1 domain from DCP1 [76] . In human, PatL1 interacts with the LSM1 -7 ring, DCP2, DDX6/RCK and EDC4 (table 1 [56] ). In addition, a weak interaction has been detected between XRN1 and PatL1 while EDC4 bridges DCP1a to DCP2 and simultaneously interacts with XRN1 through a short motif in its C-terminal extension [60, 76] . The differences in the interaction networks [61] .
The model described above for the recruitment of Dcp2 to its deadenylated mRNA substrates is valid for the general mRNA decay pathway. However, decapping can occur without the requirement for prior deadenylation in specific cases. For instance, in Saccharomycetaceae, Edc3 uses a short conserved motif to interact with ribosomal protein Rps28, and this complex binds to RPS28B mRNA, thereby triggering its rapid elimination independently of deadenylation [77] [78] [79] . S. cerevisiae Edc3 is also specifically involved in the rapid elimination of the YRA1 pre-mRNA through a deadenylation-independent decay mechanism [79] [80] [81] . Finally, during the elimination of aberrant mRNAs by nonsense-mediated mRNA decay (NMD), decapping can also occur independently of deadenylation and in this case, the decapping factors Edc3, Pat1 and Dcp2 can be directly recruited to aberrant mRNAs by the Upf1 protein, the central player of the NMD mechanism [22, 82] .
Molecular bases for Dcp1 -Dcp2 decapping holoenzyme activity
During the last decade, integrative structural biology approaches (i.e. crystal structures, NMR studies in solution and small-angle X-ray scattering (SAXS)) combined with in vivo and in vitro functional assays (yeast genetics, RNA binding assays, enzymology, etc.) have gradually put pieces of the jigsaw puzzle together to clarify the molecular bases for cap recognition and cleavage by Dcp2 and for its activation by different decapping factors. Thanks to a recent series of crystal structures of fungal Dcp1-Dcp2 holoenzymes bound to various co-activators and either a cap analogue or the m 7 GDP reaction product [26, 83, 84] , a consensus has now been reached regarding the identity of the active form of the decapping enzyme and the molecular bases for cap recognition. These studies have also paved the way toward a mechanistic understanding for the control of Dcp2 by some of its activators.
The first crystal structure of a Dcp1 -Dcp2 complex (from S. pombe) revealed a bilobed organization for the holoenzyme with a first lobe formed by the Dcp1 -Dcp2 NRD sub-complex and a second comprising the Dcp2 Nudix domain. The existence in the crystal asymmetric unit (A.U) of two radically different conformations of the holoenzyme has already revealed its dynamic nature [36] . This structure was obtained using ATP (a non-functional ligand of Dcp2) as a crystallization additive that is observed bound to the Dcp2 Nudix domain in only one of the two conformations present in the A.U. In one conformation (ATP-free open form), the Dcp1 -Dcp2 NRD module is held apart from the Dcp2 Nudix domain by a flexible hinge (figure 3a). In the second conformation (ATP-closed form; figure 3a), the Dcp1 -Dcp2 NRD module lies on the Dcp2 Nudix domain. The critical observation, made by SAXS, that Dcp1 -Dcp2 undergoes a major compaction upon addition of its substrate, initially suggested that this ATP-closed state corresponded to the active form of the enzyme. However, several lines of evidence have subsequently indicated that this closed form was incompatible with efficient substrate binding and catalysis. First, the RNA binding channel identified on the dorsal surface of the Nudix domain is partially obstructed by the Dcp1/ rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 373: 20180164 NRD module, thereby virtually preventing the interaction of the enzyme with the body of capped mRNAs [20] . Second, the NRD W43 (S. pombe numbering will be used for the sake of clarity in this section), proposed to collaborate with the Nudix glutamates to form a composite active site, is located more than 20 Å away from the Nudix helix [34] . Finally, recent NMR experiments revealed that the Dcp1 -Dcp2 complex in solution mostly adopts this closed conformation in the absence of substrate and exhibits a reduced affinity for capped mRNAs [83] . Hence, it seems now generally accepted that this compact conformation most likely corresponds to an auto-inhibited closed state of the enzyme.
Since this pioneer structure of Dcp1 -Dcp2 complex, many additional studies have converged towards the idea that the active form of the decapping holoenzyme is induced by substrate binding, which triggers large conformational rearrangements to form a composite active site competent for catalysis. Importantly, some of these studies highlighted a strictly conserved tryptophan residue (W43 in S. pombe) rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 373: 20180164 from the Dcp2 NRD acting as a 'gatekeeper' for the transition between inactive forms and the active form of the enzyme, consisting of both the NRD and Nudix Dcp2 domains sandwiching the substrate in the active site [34, 85] . Based on this model, some decapping activators were proposed to act on the decapping reaction by influencing the conformational equilibrium of the Dcp1 -Dcp2 holoenzyme [20, 34, 85, 86] . This widely accepted model for the mechanism of action of the decapping complex could only very recently be confirmed thanks to several crystal structures of the Dcp1 -Dcp2 holoenzyme bound to substrate/product and/or decapping activators which are discussed below [26, 83, 84] . Indeed, in the past two years, four crystal structures of Dcp1 -Dcp2 decapping enzyme bound to either a synthetic tightly binding bi-headed cap analogue (m7GpSpppSm7G [39] ) or m7GDP, the product of the decapping reaction [26, 83, 84] , have been determined.
One of these structures was obtained by soaking crystals of S. pombe Dcp1-Dcp2 (crystallized in a conformation similar to the ATP-bound inhibited closed form) complexed to a fragment of PNRC2 (the human orthologue of Edc1) with the m 7 Gp S ppp S m 7 G cap analogue [39, 87] . Comparison of the structures determined from the same crystals either native (3 Å resolution) or soaked (2.6 Å resolution) revealed that the addition of cap analogue induces a 258 rotation of the Dcp1/ NRD module relative to the Nudix domain (figure 3b). As a result, a new interface is formed between the NRD and Nudix domains, with Dcp2 residues, previously buried at inter-domain interfaces, now interacting with the symmetrical cap analogue. One m 7 G head is largely solvent-exposed and is recognized by two residues (Y92 and R95) present on the Dcp2 hinge region connecting the NRD and Nudix domains. The second m 7 G moiety is deeply buried in the structure and is sandwiched at the interface between the NRD and Nudix domains by the highly conserved and essential residues W43 (NRD) and Y220 (Nudix). In addition, the side chain of the strictly conserved NRD residue D47 is within hydrogenbonding distance from the N 1 and N 2 of the m 7 G guanine ring and most probably ensures specificity of Dcp2 toward guanine caps [34] . This mode of binding confirms previous indirect observations that NRD domain residues can form direct contact with the m 7 G [85] . Nevertheless, in this structure, the tetraphosphate bridge which mimics the link between the m 7 G and the mRNA body, and hence is supposed to receive the hydrolytic attack during catalysis, is located 12 Å away from the Nudix helix harbouring the catalytic glutamates. Thus, in the Dcp1-Dcp2 conformation trapped upon soaking with this cap analogue, no composite active site is formed, indicating that this structure corresponds to an inactive form. It is very likely that crystal contacts precluded conformational rearrangements of larger amplitude during the soaking procedure. This structure could correspond to a pre-catalytic conformation of the holoenzyme, in which the cap is recognized independently of the Nudix catalytic residues and is therefore protected from catalysis. This stage could then be followed by a large conformational rearrangement of Dcp2 to bring the catalytic residues proximal to the triphosphate bridge.
Concomitantly, we solved the 3.5 Å resolution structure of the Kluyveromyces lactis Dcp1 -Dcp2 holoenzyme bound to the m 7 GDP product and to the Edc3 Lm domain. This Dcp1 -Dcp2 -Edc3 ternary complex was co-crystallized with an m 7 GpppA cap analogue that was hydrolysed during the crystallization process. In this structure, the Dcp1 -Dcp2 NRD lobe adopts a radically different orientation (1208 rotation) relative to Nudix domain in comparison with the Dcp1 -Dcp2 -PNRC2 -m 7 Gp S ppp Sm 7 G structure (figure 3c; [26] ). The m 7 G cap moiety is recognized by W43 (S. pombe numbering) and D47 from the NRD, as observed in the Dcp1 -Dcp2 -PNRC2 -m 7 Gp Sppp S m 7 G structure. However, in this case, the face of the m 7 G ring, which was stacked against Y220 in the Dcp1 -Dcp2-PNRC2-m 7 Gp S ppp S m 7 G structure, now interacts with the loop 190s of the Nudix domain in agreement with previous observations made by NMR [86] . Interestingly, in this structure, the Nudix helix and in particular E147 and K129, which were proposed to act as general base and acid during the decapping reaction, are proximal to the phosphate groups of the cap and are thus ideally positioned for catalysis [86] .
In conclusion, the conformation of this Dcp1 -Dcp2 -Edc3-m 7 GDP complex is in complete agreement with the large majority of functional data that were accumulated on the decapping enzyme in the last decade, supporting the notion of the formation of a split active site at the interface between Dcp2 NRD and Nudix domain upon cap binding. This structure then corresponds to the active conformation of the Dcp1 -Dcp2 holoenzyme. Two subsequent studies describing the crystal structures of S. pombe Dcp1 -Dcp2 -Edc1-m 7 GDP (3.1 Å resolution [83] ) and of K. lactis
Dcp1 -Dcp2 -Edc1 -Edc3-m 7 Gp S ppp S m 7 G (2.84 Å resolution; figure 3c ; [84] ) complexes as well as the conformation of the Dcp1 -Dcp2 holoenzyme in solution and in the absence or presence of various partners (Edc1, a capped RNA substrate or m 7 GDP product) using TROSY (transverse relaxation optimized spectroscopy)-based NMR [83] , confirmed that the K. lactis Dcp1 -Dcp2 -Edc3-m 7 GDP structure represents not only the post-catalytic conformation of the enzyme but more generally the active form of the decapping enzyme. So far, no structure of the Dcp1 -Dcp2 holoenzyme bound to a capped RNA substrate has been determined, thereby limiting our knowledge on RNA recognition by this complex. However, some information can be gleaned from site-directed mutagenesis studies and from the structure of the K. lactis Dcp1 -Dcp2 -Edc1-Edc3-m 7 Gp S ppp S m 7 G complex (figure 3c; [19, 20, 36, 84] ). Indeed, in this very recent structure, one of the m 7 G rings lies on the side chain of the strongly conserved aromatic residue F223 (Y220 in S. pombe Dcp2), which contributes to the preference of the Dcp2 enzymes for purines as the first transcribed nucleotide [84] . This m 7 G orients its 3 0 -OH group towards a positively charged region formed by Dcp2 Box B and surrounding residues, whose substitution with alanine affects the affinity of RNA capped substrates [20, 36] . Interestingly, the same region interacts with ATP in the initially determined closed form of S. pombe Dcp1-Dcp2 [36] and also with a guanine ring from a short RNA bound to the structure of Escherichia coli RppH pyrophosphatase enzyme, which initiates bacterial 5 0 mRNA decay by removing pyrophosphate from the 5 0 triphosphorylated end of RNAs [88] .
Mode of action of the enhancers of decapping
As discussed above, the Dcp2 enzyme adopts different conformations in solution, many of these being incompatible with cap recognition and hydrolysis. The recent structurefunction studies have also contributed to clarify the role of rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 373: 20180164
Edc1-like and Edc3 activators in Dcp1 -Dcp2 activation and have revealed that these two decapping factors can simultaneously interact with the active form of the decapping holoenzyme [26, 39, 43, 83, 84] .
(a) Edc1-like proteins
Four structures of fungal decapping holoenzymes bound to Edc1-like activators have been solved recently [39, 40, 83, 84] , each one bringing new information on the mechanism of Dcp1 -Dcp2 activation by Edc1-like proteins and also leading to the identification of PNRC2 as the metazoan orthologue of fungal Edc1 [39, 40] . One common feature to these structures is the recognition of the PRS motif of the Edc1-like proteins by the aromatic cleft of the Dcp1 EVH1 domain as previously described for the complex between human DCP1a and PNRC2 [38] . Interestingly, PRS motifs capable of Dcp1 binding have also been identified in other components of the decapping machinery in S. pombe (Dcp2 C-terminal part, Dhh1, Pat1 and Xrn1 [43] ) and in fruit-fly (Xrn1 [76] ). While the functional significance of some of these interactions (i.e. Dhh1 and Pat1) needs to be confirmed, this could indicate that, at least in these organisms, several decapping factors compete together to interact with Dcp1 and thereby might exert either an inhibitory or an activating effect.
The most important input from these recent crystal structures is the clarification of the role played by the YAGX 2 F activation motif located upstream of the PRS sequence. This motif is defined in the electron density maps of three structures [40, 83, 84] . The first structure of S. pombe Dcp1-Dcp2 to be reported in complex with Edc1 was obtained in the absence of a cap analogue or of the m 7 GDP product [40] . In this complex, the DAM from Edc1 folds as a b-strand that extends the Nudix central bsheet and also stacks against several residues from the NRD (including the side chain of the 'gatekeeper' W43), thereby bridging the NRD and Nudix domain from Dcp2. This structure shows a unique conformation of the decapping holoenzyme where the composite active site is not formed and hence corresponds to an inactive conformation. It could represent an early conformation of the decapping complex compatible with an initial scanning along mRNAs for the presence of a cap to cleave. However, an overview of the dynamics of the decapping complex in solution reported that Edc1 does not influence the structure of Dcp1 -Dcp2, in the absence of a capped RNA substrate [83] . Whether this conformation is only weakly populated in solution or simply results from crystal packing remains an open question.
The two other structures determined in the presence of Edc1 (S. pombe Dcp1 -Dcp2 -Edc1-m 7 GDP and K. lactis
Dcp1 -Dcp2 -Edc1 -Edc3-m 7 Gp S ppp S m 7 G) correspond to the active form of the decapping holoenzyme and reveal that the DAM does not directly contact the cap [83, 84] . Instead, the YAG segment of this motif binds to a channel present at the interface between the Nudix and NRD domain from Dcp2, near the hinge region, while the side chain of the downstream phenylalanine protrudes in a pocket formed at the interface between Dcp1 and the NRD (figure 4). Hence, this motif can clearly affect the conformational equilibrium of the decapping holoenzyme by providing an anchoring point to constrain both Dcp2 domains in the active conformation. This explains why the activation of Dcp1 -Dcp2 by Edc1 results from a strong decrease (about 100-fold) in the K m and an increase (about 10-fold) in k max of the enzyme [37, [83] [84] [85] . Importantly, as the Edc1-2 activators are described as RNAbinding proteins [30, 37] , they may further increase the affinity of the decapping complexes for RNA in vivo by providing additional RNA-binding modules.
(b) Edc3
Edc3 is a conserved decapping activator known to stimulate decapping both in vivo [22, 24, 89] and in vitro [25, 32] . It was also reported to act in a transcript-specific manner [22, 77, 78, 80, 81] . Recent structure-function studies have unravelled parts of the mechanism used by Edc3 to activate Dcp1 -Dcp2 [25, 26] . The comparison of the Dcp1-Dcp2 and Dcp1-Dcp2-Edc3-m 7 GDP crystal structures from K. lactis suggests that binding of the Edc3 LSm domain immediately downstream of Dcp2 Box B results in the formation of a long a-helix protruding from the Nudix domain (figure 3c; [26] ). Consequently, the Edc3 LSm is held approximately 50 Å apart from the Nudix helix and is thereby unlikely to influence the active site chemistry. Instead, rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 373: 20180164 the long a-helix stabilized upon Edc3 binding is enriched in basic residues and extends the positively charged area at the exit of the active site where the first transcribed nucleotide of the capped RNA substrate binds. This rationalizes the increased affinity of the Dcp1-Dcp2 complex for an uncapped RNA in the presence of the Edc3 LSm domain [26] . As for Edc1-like activators, Edc3 could further increase the affinity of the decapping complex for RNA substrates by providing additional binding surfaces present within its C-terminal YjeFN domain [52, 79] . This possibility could also explain the transcript-specific nature of Edc3-mediated decapping activation, provided that Edc3 exhibits RNA binding preferences.
Another consequence of the binding of the Edc3 LSm domain to Dcp2 could also be its contribution to the release of the self-inhibitory effect exerted by Dcp2 sequences located downstream of the Edc3 binding site in S. cerevisiae and S. pombe proteins [22, 23] . Other proteins known to bind to the Dcp2 C-terminal extension (i.e. Pat1 [22] ) could further contribute to unlock this auto-inhibited form of the Dcp1 -Dcp2 holoenzyme. Additional investigation is definitely needed to fully understand the exact mechanism used by Edc3 to activate decapping. In particular, the information gathered so far mostly derives from studies performed using S. cerevisiae and S. pombe decapping factors but should differ in metazoans, where the Edc3 binding motif was transferred from Dcp2 to the C-terminus of Dcp1 [25] .
Conclusion and perspectives
Over the past two years, various structures of Dcp2 enzyme bound to a cap analogue, the m 7 GDP reaction product and/ or different activators have considerably improved our understanding of capped mRNA recognition and cleavage by Dcp2 as well as of the activation mechanisms used by some of its well-characterized activators. Most of these structures provide snapshots along the pathway leading from the unbound and inactive forms of the holoenzyme to its active form bound to its m 7 GDP product, while others could result from crystallization artefacts. Hence, elegant integrative structural biology and biochemical approaches have played a crucial role in identifying the right structure that corresponds to the active conformation of the holoenzyme. Nevertheless, the current picture of the Dcp1-Dcp2 + Edc1 + Edc3 complexes bound to either a cap analogue or the m 7 GDP product does not answer all questions. First, a higher resolution structure of the active form of Dcp2 bound to a cap analogue is needed to precisely dissect the catalytic mechanism underlying the decapping reaction (i.e. precise role of the catalytic residues and metals). Second, given the large variety of cap structures found in higher eukaryotes, structures of the active form of metazoan Dcp2 bound to various cap analogues (such as m 7 Gpppm 6 A or 2 0 -O-methylated caps) are also required to understand how these cap structures are recognized and can influence the decapping efficiency. Such structures should also help in visualizing the differences between yeast and metazoan decapping machineries, i.e. the rewiring of the interaction network, the role of EDC4 in metazoans etc. Third, a structure with a capped mRNA substrate should also be very informative to map precisely the RNA path at the surface of the decapping enzyme. Fourth, with the recent technical improvements in cryo-electron microscopy, one of the future goals will be to determine the atomic structures of larger decapping complexes, either from recombinant sources or purified directly from cell extracts.
Finally, another important aspect omitted in this review owing to space constraints is the function of the decapping holoenzyme and its cofactors in the cellular context of P-bodies, cytoplasmic RNP granules composed of translationally repressed mRNAs and mRNA decay machinery components [53] . With the methodological developments in electron microscopy and the recent purification of human P-bodies, the next decade may bring invaluable information on these cytoplasmic foci using, for instance, cryo-electron tomography to visualize these particles at nanometre resolution.
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